Integrative review identifies factors correlating schizophrenia with metabolic diseases, suggesting integrated care is crucial.
Key Points
Metabolic diseases are prevalent among individuals with schizophrenia, complicating treatment outcomes and quality of life.
Key factors include prolonged use of antipsychotics, endocrine disorders, genetic predisposition, and unhealthy lifestyles, which impact both conditions.
This integrative review analyzed publications from 2017 to 2023, utilizing databases like VHL and SciELO for comprehensive insights.
Integrated health approaches are essential, as there is a bidirectional relationship affecting treatment and symptoms for those with schizophrenia.